Hypervision Surgical
PrivateLast Round
Series A
Apr 29, 2026
Total Funding Raised
$31.38M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Hypervision Surgical operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Series A round in April 2026.
Hypervision Surgical is a MedTech company that develops an AI-powered hyperspectral imaging platform for real-time, data-driven tissue analysis to improve surgical precision and patient safety.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical Devices, Medical AI, Computer Vision
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hypervision Surgical Comparables
Compare Hypervision Surgical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Activ Surgical | 89% | |
| Diaspective Vision GmbH | 81% | |
| Perfusion Tech ApS | 81% |
For institutional investors. Book with your work email.
Hypervision Surgical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 29, 2026 | ||||
| Grant | Oct 1, 2024 | ||||
| Seed | Jun 1, 2023 | ||||
| Grant | Mar 9, 2023 | ||||
| Grant | Feb 17, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Hypervision Surgical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| LifeX Ventures | Series A, Seed |
| IP Group | Series A |
| LifeX Ventures | Seed |
| Daycrest | Series A |
| The Worshipful Company of Cutlers | Grant |
| SAGES Ingenuity | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 18, 2026
Grew 17% QoQ, from 24 to 28 employees.
- Jun 30, 2026
Grew 16% QoQ from 25 to 29 employees.
For institutional investors. Book with your work email.
Hypervision Surgical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Hypervision Surgical's valuation, stock price, and market status.
Is Hypervision Surgical a public or private company?
Hypervision Surgical is a private company.
What is the current stock price of Hypervision Surgical?
Hypervision Surgical is a private company, so its shares have no public market price. Caplight tracks Hypervision Surgical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hypervision Surgical worth (valuation)?
Valuation information for Hypervision Surgical is not publicly available.
Can I buy Hypervision Surgical stock?
Hypervision Surgical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hypervision Surgical's last funding round?
Hypervision Surgical's most recent funding round was Series A on April 29, 2026.
Who are the main investors in Hypervision Surgical?
Key investors in Hypervision Surgical include LifeX Ventures, HERAN Partners, Redalpine, ZEISS Ventures, Heal Capital.
Will Hypervision Surgical IPO soon?
No public IPO plans have been announced for Hypervision Surgical.
How can I track Hypervision Surgical secondary market activity?
Caplight tracks bids, offers, and trades in Hypervision Surgical's shares on secondary markets.